Download.pdf

Reitmans (Canada) Limited's Management's Discussion and Analysis (MD&A) for the 13 and 26 weeks ended July 29, 2023, discusses the company's financial performance, strategies, and risks. The MD&A is based on unaudited condensed consolidated interim financial statements prepared in accordance with International Financial Reporting Standards (IFRS). The company's financial results are compared to the same periods in the previous year, with the 13 weeks ended July 29, 2023, referred to as the "second quarter of 2024" and the 26 weeks ended July 29, 2023, referred to as "year to date fiscal 2024". The MD&A contains forward-looking statements, which are subject to numerous risks and uncertainties, including foreign currency fluctuations, changes in economic conditions, and heightened competition. The company cautions that actual results may differ materially from those expressed or implied in the forward-looking statements. The MD&A also discusses non-GAAP financial measures and supplementary financial measures, which are not recognized under IFRS.